BRADOSOL MULTIFLAVOUR LOZ 2.4MG 2.4 MG
HEXYLRESORCINOL : 2.4 MG · DIN 01919148 · CIBA SELF MEDICATION
Health Canada status: CANCELLED POST MARKET
What is BRADOSOL MULTIFLAVOUR LOZ 2.4MG?
BRADOSOL MULTIFLAVOUR LOZ 2.4MG 2.4 MG contains HEXYLRESORCINOL : 2.4 MG. It is listed in the Health Canada Drug Product Database under DIN 01919148, held by CIBA SELF MEDICATION, supplied as LOZENGE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 09-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01919148 |
|---|---|
| Brand name | BRADOSOL MULTIFLAVOUR LOZ 2.4MG |
| Generic / active ingredient | HEXYLRESORCINOL : 2.4 MG |
| Manufacturer | CIBA SELF MEDICATION |
| Strength | 2.4 MG |
| Dosage form | LOZENGE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R02AA12 HEXYLRESORCINOL |
| AHFS class | 52:04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 09-Sep-1996 |
| Original market date | 1992-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 01919148 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1919148 |
| Brand name | BRADOSOL MULTIFLAVOUR LOZ 2.4MG |
| Active ingredient / INN | HEXYLRESORCINOL : 2.4 MG |
| ATC code | R02AA12 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R02 |
| AHFS class | 52:04.92 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | CIBA SELF MEDICATION |
Which pack is which?
| Strength on the label | 2.4 MG |
|---|---|
| Dosage form | LOZENGE |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code R02AA12 HEXYLRESORCINOL. 3 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BRADOSOL LOZENGES EXTRA STRENGTH 3.5MG | 3.5 MG | LOZENGE | COLUMBIA LABORATORIES CANADA INC | MARKETED | DIN 00895466 |
| STREPSILS ANAESTHETIC FORMULA | 2.4 MG | LOZENGE | RB HEALTH (CANADA) INC. | MARKETED | DIN 02243888 |
| STREPSILS EXTRA BLACK CHERRY | 2.4 MG | LOZENGE | RB HEALTH (CANADA) INC. | MARKETED | DIN 02263998 |
| ANTISEPTIC SORE THROAT LOZ. (LEMON FLAVOUR) | 2.4 MG | LOZENGE | H.J. SUTTON INDUSTRIES LTD. | CANCELLED POST MARKET | DIN 02227568 |
| ANTISEPTIC SORE THROAT LOZ(HONEY EUCALYP.FL) | 2.4 MG | LOZENGE | H.J. SUTTON INDUSTRIES LTD. | CANCELLED POST MARKET | DIN 02227541 |
| ANTISEPTIC SORE THROAT LOZ(MINT MENTHOL FLV) | 2.4 MG | LOZENGE | H.J. SUTTON INDUSTRIES LTD. | CANCELLED POST MARKET | DIN 02228424 |
| ANTISEPTIC THROAT LOZENGES (WITH HEXYLRESORCINOL) | 2.4 MG | LOZENGE | H.J. SUTTON INDUSTRIES LTD. | CANCELLED POST MARKET | DIN 02228432 |
| BRADOSOL LOZENGES EXTRA STRENGTH 3.5MG MINT | 3.5 MG | LOZENGE | COLUMBIA LABORATORIES CANADA INC | DORMANT | DIN 00894214 |
| BRADOSOL LOZENGES REGULAR STRENGTH 2.4MG (CHERRY, MINT, LEMON, ORANGE, HONEY-EUCALYPTUS) | 2.4 MG | LOZENGE | COLUMBIA LABORATORIES CANADA INC | DORMANT | DIN 00846589 |
| BRONCHODEX PAST.ANTISEP.-S.MIEL ET EUCALYPT. | 2.4 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 02033771 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.